These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 31906959)
21. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database. Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371 [TBL] [Abstract][Full Text] [Related]
22. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal. Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762 [TBL] [Abstract][Full Text] [Related]
23. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study. Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127 [TBL] [Abstract][Full Text] [Related]
24. Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer. Teufel A; Gerken M; Hartl J; Itzel T; Fichtner-Feigl S; Stroszczynski C; Schlitt HJ; Hofstädter F; Klinkhammer-Schalke M BMC Cancer; 2015 May; 15():419. PubMed ID: 25985893 [TBL] [Abstract][Full Text] [Related]
25. Competing nomograms help in the selection of elderly patients with colon cancer for adjuvant chemotherapy. Li D; Zhong C; Tang X; Yu L; Ding K; Yuan Y J Cancer Res Clin Oncol; 2018 May; 144(5):909-923. PubMed ID: 29460089 [TBL] [Abstract][Full Text] [Related]
26. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study. Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156 [TBL] [Abstract][Full Text] [Related]
27. Administration of adjuvant chemotherapy in older patients with Stage III colon cancer: an observational study. van den Broek CBM; Puylaert CCEM; Breugom AJ; Bastiaannet E; de Craen AJM; van de Velde CJH; Liefers GJ; Portielje JEA Colorectal Dis; 2017 Oct; 19(10):O358-O364. PubMed ID: 28873267 [TBL] [Abstract][Full Text] [Related]
28. Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients. Birkett RT; Chamely E; Concors SJ; Bleier JI; Aarons CB; Shanmugan S; Saur NM; Paulson EC Clin Colorectal Cancer; 2019 Dec; 18(4):292-300. PubMed ID: 31447135 [TBL] [Abstract][Full Text] [Related]
29. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea. Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187 [TBL] [Abstract][Full Text] [Related]
30. [Benefit of adjuvant 5-fluorouracil based chemotherapy for colon cancer: a retrospective cohort study]. Mondaca S; Villalón C; Leal JL; Zúñiga Á; Bellolio F; Padilla O; Palma S; Garrido M; Nervi B Rev Med Chil; 2016 Feb; 144(2):145-51. PubMed ID: 27092667 [TBL] [Abstract][Full Text] [Related]
31. Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70. Lu CS; Chang PY; Chen YG; Chen JH; Wu YY; Ho CL PLoS One; 2015; 10(9):e0138632. PubMed ID: 26382962 [TBL] [Abstract][Full Text] [Related]
32. Eligibility of Real-World Patients With Stage II and III Colon Cancer for Adjuvant Chemotherapy Trials. Batra A; Kong S; Cheung WY Clin Colorectal Cancer; 2020 Dec; 19(4):e226-e234. PubMed ID: 32636076 [TBL] [Abstract][Full Text] [Related]
33. Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study. Gao P; Huang XZ; Song YX; Sun JX; Chen XW; Sun Y; Jiang YM; Wang ZN BMC Cancer; 2018 Mar; 18(1):234. PubMed ID: 29490625 [TBL] [Abstract][Full Text] [Related]
34. Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer. Manjelievskaia J; Brown D; McGlynn KA; Anderson W; Shriver CD; Zhu K JAMA Surg; 2017 May; 152(5):452-459. PubMed ID: 28122072 [TBL] [Abstract][Full Text] [Related]
35. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer. Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117 [TBL] [Abstract][Full Text] [Related]
36. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis. Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. Iwashyna TJ; Lamont EB J Clin Oncol; 2002 Oct; 20(19):3992-8. PubMed ID: 12351596 [TBL] [Abstract][Full Text] [Related]
38. Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008. van den Broek CB; Bastiaannet E; Dekker JW; Portielje JE; de Craen AJ; Elferink MA; van de Velde CJ; Liefers GJ; Kapiteijn E Acta Oncol; 2013 Jun; 52(5):941-9. PubMed ID: 23145507 [TBL] [Abstract][Full Text] [Related]
39. Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study. Babaei M; Balavarca Y; Jansen L; Lemmens V; van Erning FN; van Eycken L; Vaes E; Sjövall A; Glimelius B; Ulrich CM; Schrotz-King P; Brenner H Int J Cancer; 2018 Apr; 142(7):1480-1489. PubMed ID: 29159866 [TBL] [Abstract][Full Text] [Related]
40. Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study. Ortiz-Ortiz KJ; Tortolero-Luna G; Ríos-Motta R; Veintidós-Feliú A; Hunter-Mellado R; Torres-Cintrón CR; Suárez-Ramos T; Magno P PLoS One; 2018; 13(3):e0194415. PubMed ID: 29584752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]